Event-Driven Stocks

Bruker Cellular Analysis, Inc.

Healthcare · Laboratory Analytical Instruments · DE · SEC filings ↗ · Compare ⊕

Signs● 2 good● 4 warning● 1 severedetails ↓

Financials

SEC XBRL · annual
 FY22FY21FY20FY19FY18
Revenue$78.6M$85.4M$64.3M$56.7M$31.3M
Operating income−$98.1M−$70.8M−$40.4M−$16.5M−$21.2M
Net income−$98.0M−$71.7M−$41.6M−$18.3M−$23.3M
Total assets$226.1M$287.3M$299.7M$131.0M—
Total liabilities$84.0M$79.0M$54.9M$47.2M—
Equity$142.1M$208.2M$244.8M$83.8M$97.6M
EPS (diluted)$-1.42$-1.08$-1.39$-7.46—
Shares out.67.7M64.9M64.5M3.1M—

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2022
Operating margin
−124.8%
Net margin
−124.7%
Return on equity
−69.0%
Return on assets
−43.4%
Return on capital (ROCE)
−54.3%
Liabilities / assets
37.2%
Debt / equity
0.59×
Book value / share
$2.10
Revenue growth (YoY)
−8.0%
Net income growth (YoY)
—

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2022
Altman Z″ (distress)
-2.54distress
Accruals / assets
−22.3%clean
Beneish M-Score
-4.02normal
Piotroski F-Score
2/9weak

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
35
/ 100
Profitability 0Growth 0Catalyst 33Earnings quality 67Financial strength 75

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

● 1 severe● 4 warning● 2 good
  • Altman Z″ in the distress zone
  • Operating losses (negative operating margin)
  • Reported a net loss
  • Revenue declined year-over-year
  • Negative operating cash flow
  • Conservative leverage (liabilities < 50% of assets)
  • Clean earnings (low accruals)

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (1)

Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.